Skip navigation

Refine by Type

Results 1 - 10 of 18 for PAZOPANIB
  1. Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... the intestines, heart problems, and slow wound healing. Pazopanib (Votrient ® ) Pazopanib is another drug that blocks several tyrosine kinases ...
  3. ... in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), axitinib (Inlyta ® ), ... Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat other types of ...
  4. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hydrochloride Pamidronate Disodium Panitumumab Paraplat (Carboplatin) Paraplatin (Carboplatin) Pazopanib Hydrochloride Pegaspargase Peginterferon Alfa-2b PEG-Intron (Peginterferon ...
  5. ... grow beyond a certain size. Bevacizumab (Avastin ® ) and pazopanib (Votrient ® ) are examples of drugs that target blood ...
  6. ... be used alone or with more traditional chemotherapy. Pazopanib is a type of targeted therapy drug that ...
  7. ... nilotinib (Tasigna) and dasatinib (Sprycel) in chordoma, and pazopanib (Votrient ® ), everolimus (Afinitor ® ), and vismodegib (GDC-0449) in ...
  8. ... or proteins, such as sorafenib (Nexavar), bevacizumab (Avastin), pazopanib (Votrient), and everolimus (Afinitor), are now being studied ...
  9. ... drugs are also being looked at, as well. Pazopanib (Votrient ® ) is a targeted therapy drug that, like ...
  10. ... against NPC, including bevacizumab (Avastin ® ), sorafenib (Nexavar ® ), and pazopanib (Votrient ® ). Immunotherapy NPC seems to be caused at ...
previous · 1 · 2 · next